At 2 h after radiotherapy, the top canonical pathways in NSCLC mainly include the BAG2 signaling pathway, the FAT10 signaling pathway, and inhibition of ARE-mediated mRNAs. The gene discussed is UBD; the disease is non-small cell lung carcinoma.